Montelukast-d6

CAS : 1093746-29-2

Ref. 3D-TTB74629

Informations sur le produit

• Nom: Montelukast-d6
• CAS: 1093746-29-2

Description

Montelukast-d6 is an analog of Montelukast, a drug used for the treatment of asthma and allergic rhinitis. Montelukast-d6 has been shown to have anticancer properties by inhibiting the activity of certain kinases that are involved in cancer cell growth and proliferation. This drug has been found to induce apoptosis in human cancer cells, making it a promising candidate for cancer therapy. Montelukast-d6 is also a potent inhibitor of protein kinases, which play a key role in tumor development and progression. This inhibitor has been shown to inhibit the growth of tumors in mice, suggesting its potential as an effective anticancer agent. Montelukast-d6 can be detected in urine samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques, making it useful for monitoring drug levels during clinical trials or treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 592.2 g/mol
• Formule: C₃₅H₃₆ClNO₃S
• Degré de pureté: Min. 95%